|
Active substance |
Eribulin |
|
Holder |
Eisai SA |
|
Status |
Closed |
|
Indication |
Treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease. |
|
Public documents |
|
|
Last update |
03/05/2018 |
Halaven®
Last updated on